103 related articles for article (PubMed ID: 6270053)
1. In-vitro efficacy of cefotiam in combination with four aminoglycosides on staphylococci and Gram-negative bacteria.
Daschner FD; Steffens A; Schneider H
J Antimicrob Chemother; 1981 Sep; 8(3):239-41. PubMed ID: 6270053
[No Abstract] [Full Text] [Related]
2. [In vitro study of the synergistic effect of cefotiam- aminoglycoside combinations on strains of low susceptibility to this cephalosporin].
Husson MO; Izard D; Leclerc H
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):466-8. PubMed ID: 3911141
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial activity of cefotiam combinations against Enterobacteriaceae moderately susceptible or resistant to this new cephalosporin.
Husson MO; Izard D; Leclerc H
Drugs Exp Clin Res; 1986; 12(4):325-7. PubMed ID: 3459642
[TBL] [Abstract][Full Text] [Related]
4. In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Proteus strains.
Daschner FD; Steffens A; Langmaack H
Chemotherapy; 1979; 25(5):282-5. PubMed ID: 113178
[TBL] [Abstract][Full Text] [Related]
5. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
Bovelacci A; Montini G; Ramacciotti PG
Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
[TBL] [Abstract][Full Text] [Related]
6. In vitro aminoglycoside resistance of gram-negative bacilli and staphylococci isolated from blood in Sweden 1980-1984.
Bengtsson S; Bernander S; Brorson JE; Dornbusch K; Forsgren A; Hallander H; Henning C; Holm S; Malmborg AS; Nilsson L
Scand J Infect Dis; 1986; 18(3):257-63. PubMed ID: 3738436
[TBL] [Abstract][Full Text] [Related]
7. Combination effect of cefmenoxime with four aminoglycosides on Enterobacteriaceae susceptible and moderately susceptible to this new cephalosporin.
Husson MO; Izard D; Bryskier A; Vincent P; Leclerc H
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):383-7. PubMed ID: 6091368
[TBL] [Abstract][Full Text] [Related]
8. Aminoglycoside resistance among blood culture isolates.
Huovinen P; Grönroos P; Herva E; Katila ML; Klossner ML; Renkonen OV; Toivanen P
J Clin Microbiol; 1984 Jul; 20(1):65-9. PubMed ID: 6378968
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
DiPersio JR; Krafczyk TL
Chemotherapy; 1980; 26(5):323-33. PubMed ID: 7389428
[TBL] [Abstract][Full Text] [Related]
10. Resistance of gram-negative bacilli and staphylococci from blood cultures to aminoglycoside antibiotics. Comparison of 3 in vitro investigations from Austria 1982-1988.
Mittermayer H; Rotter M; Breitfellner G; Riezinger F; Thiel W; Binder L; Watschinger R
Zentralbl Bakteriol; 1990 Apr; 272(4):448-57. PubMed ID: 2113808
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
Knothe H
J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
Braveny I; Voeckl J; Machka K
Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of the antibacterial activity of amikacin (BB-K8) with other aminoglycosides against pathogens recently isolated from clinical materials (author's transl) ].
Kosakai N; Oguri T
Jpn J Antibiot; 1975 Aug; 28(4):530-7. PubMed ID: 240047
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
Yourassowsky E; Schoutens E; Vanderlinden MP
Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
[TBL] [Abstract][Full Text] [Related]
15. The screening of four aminoglycosides in the selective decontamination of the digestive tract in mice.
van der Waaij D; Aberson J; Thijm HA; Welling GW
Infection; 1982 Jan; 10(1):35-40. PubMed ID: 6802766
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of the antibacterial effects of gentamycin, tobramycin, dibekacin and amikacin in urinary germs].
Rothenberger K; Friesen A; Streifinger W; Hofstetter A
Fortschr Med; 1981 Oct; 99(40):1669-72. PubMed ID: 7298004
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of the sensitivity of Enterobacteriaceae and Pseudomonas aeruginosa with 4 aminoglycosides].
Turgeon P; Lamothe F; Vincelette J; Gaudreau C; Bourgault AM; Turgeon F
Union Med Can; 1984 Jun; 113(6):522-4. PubMed ID: 6435299
[No Abstract] [Full Text] [Related]
18. [Current status of aminoglycoside resistance in hospital Enterobacteriaceae].
Ronco E; Migueres ML; Vacheron F; Guenounou M
Pathol Biol (Paris); 1988 May; 36(5):430-4. PubMed ID: 3043339
[TBL] [Abstract][Full Text] [Related]
19. Selective growth of resistant variants during incubation of Enterobacteriaceae with four aminoglycosides.
Nilsson L; Sörén L
J Antimicrob Chemother; 1986 Sep; 18(3):317-24. PubMed ID: 3771425
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
[No Abstract] [Full Text] [Related]
[Next] [New Search]
